Biomea Fusion Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.36

-0.07 (-4.90%)

As of May 16, 2:15 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 1 8%

Sell 1 8%

Price Target

Analyst Price Target +107.4% upside

Low Target $1.78

Average Target $2.82

High Target $3.37

Current Price $1.36

Current
$1.36

Target
$2.82

$1.78 $2.82 avg $3.37

Scenario Analysis

Bear Case

$1.78

30.9%

Low target

Base Case

$2.82

+107.4%

Avg target

Bull Case

$3.37

+147.8%

High target

Risk/Reward

4.8x

Highly favorable

Price in Context

52-Week High

$3.08

-55.8% from high

52-Week Low

$0.87

+56.0% from low

Target vs 52W High

$2.82

-8.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%